Alzheimer’s disease facts and figures. Alzheimers Dement. 2023;19(4):1598–695.

Article  Google Scholar 

Collaborators, G.B.D.D.F. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(2):e105–25.

Article  Google Scholar 

Hansson O, et al. The Alzheimer’s Association appropriate use recommendations for blood biomarkers in Alzheimer’s disease. Alzheimers Dement. 2022;18(12):2669–86.

Article  PubMed  CAS  Google Scholar 

Teunissen CE, et al. Blood-based biomarkers for Alzheimer’s disease: towards clinical implementation. Lancet Neurol. 2022;21(1):66–77.

Article  PubMed  CAS  Google Scholar 

Lee CS, et al. Associations between recent and established ophthalmic conditions and risk of Alzheimer’s disease. Alzheimers Dement. 2019;15(1):34–41.

Article  PubMed  Google Scholar 

Hwang PH, et al. Ophthalmic conditions associated with dementia risk: The Cardiovascular Health Study. Alzheimers Dement. 2021;17(9):1442–51.

Article  PubMed  Google Scholar 

Gregory RL. Origin of eyes and brains. Nature. 1967;213(5074):369–72.

Article  PubMed  CAS  Google Scholar 

Subramanian ML, et al. Neurofilament light chain in the vitreous humor of the eye. Alzheimers Res Ther. 2020;12(1):111.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sheikh Z, et al. The association of vitreous biomarker levels and optical coherence tomography markers to cognitive status. Invest Ophthalmol Vis Sci. 2023;64(8):5276.

Google Scholar 

Vig V, et al. Vitreous humor biomarkers reflect pathological changes in the brain for Alzheimer’s disease and chronic traumatic encephalopathy. J Alzheimers Dis. 2023;93(3):1181–93.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bai J, et al. Association of cognitive function with neurofilament light chain in the aqueous humor of human eye. Front Aging Neurosci. 2022;14:1027705.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kwak DE, et al. Alterations of aqueous humor Abeta levels in Abeta-infused and transgenic mouse models of Alzheimer disease. PLoS ONE. 2020;15(1):e0227618.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Janciauskiene S, et al. Detection of Alzheimer peptides and chemokines in the aqueous humor. Eur J Ophthalmol. 2011;21(1):104–11.

Article  PubMed  Google Scholar 

Inoue T, Kawaji T, Tanihara H. Elevated levels of multiple biomarkers of Alzheimer’s disease in the aqueous humor of eyes with open-angle glaucoma. Invest Ophthalmol Vis Sci. 2013;54(8):5353–8.

Article  PubMed  CAS  Google Scholar 

Kallo G, et al. Changes in the chemical barrier composition of tears in Alzheimer’s disease reveal potential tear diagnostic biomarkers. PLoS ONE. 2016;11(6):e0158000.

Article  PubMed  PubMed Central  Google Scholar 

Kenny A, et al. Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer’s disease. Sci Rep. 2019;9(1):15437.

Article  PubMed  PubMed Central  Google Scholar 

Del Prete S, Marasco D, Sabetta R, Del Prete A, Marino FZ, Franco R, Troisi S, Troisi M, Cennamo G. Tear Liquid for Predictive Diagnosis of Alzheimer’s Disease. Reports. 2021;4(3):26. https://doi.org/10.3390/reports4030026.

Article  Google Scholar 

Gijs M, et al. Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration. Sci Rep. 2021;11(1):22675.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Karampatakis V, et al. Comparison between normal values of 2- and 5-minute Schirmer test without anesthesia. Cornea. 2010;29(5):497–501.

Article  PubMed  Google Scholar 

Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63.

Article  PubMed  PubMed Central  Google Scholar 

Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res. 1999;8(2):135–60.

Article  PubMed  CAS  Google Scholar 

Oktem EO, et al. The relationship between the degree of cognitive impairment and retinal nerve fiber layer thickness. Neurol Sci. 2015;36(7):1141–6.

Article  PubMed  Google Scholar 

Cunha LP, et al. Macular thickness measurements with frequency domain-OCT for quantification of retinal neural loss and its correlation with cognitive impairment in Alzheimer’s disease. PLoS ONE. 2016;11(4):e0153830.

Article  PubMed  PubMed Central  Google Scholar 

Garcia-Martin ES, et al. Macular thickness as a potential biomarker of mild Alzheimer’s disease. Ophthalmology. 2014;121(5):1149-1151 e3.

Article  PubMed  Google Scholar 

den Haan J, et al. Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer’s disease and controls. Alzheimers Dement (Amst). 2018;10:49–55.

Article  Google Scholar 

Garcia-Martin E, et al. Ganglion cell layer measurements correlate with disease severity in patients with Alzheimer’s disease. Acta Ophthalmol. 2016;94(6):e454–9.

Article  PubMed  Google Scholar 

Cunha JP, et al. OCT in Alzheimer’s disease: thinning of the RNFL and superior hemiretina. Graefes Arch Clin Exp Ophthalmol. 2017;255(9):1827–35.

Article  PubMed  Google Scholar 

Liu S, et al. The association between retinal neuronal layer and brain structure is disrupted in patients with cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2016;54(2):585–95.

Article  PubMed  Google Scholar 

Trebbastoni A, et al. Attenuation of choroidal thickness in patients with Alzheimer disease: evidence from an Italian prospective study. Alzheimer Dis Assoc Disord. 2017;31(2):128–34.

Article  PubMed  Google Scholar 

Bayhan HA, et al. Evaluation of the chorioretinal thickness changes in Alzheimer’s disease using spectral-domain optical coherence tomography. Clin Exp Ophthalmol. 2015;43(2):145–51.

Article  PubMed  Google Scholar 

Gharbiya M, et al. Choroidal thinning as a new finding in Alzheimer’s disease: evidence from enhanced depth imaging spectral domain optical coherence tomography. J Alzheimers Dis. 2014;40(4):907–17.

Article  PubMed  Google Scholar 

Cheung CY, et al. Retinal ganglion cell analysis using high-definition optical coherence tomography in patients with mild cognitive impairment and Alzheimer’s disease. J Alzheimers Dis. 2015;45(1):45–56.

Article  PubMed  CAS  Google Scholar 

O’Bryhim BE, et al. Association of preclinical Alzheimer disease with optical coherence tomographic angiography findings. JAMA Ophthalmol. 2018;136(11):1242–8.

Article  PubMed  PubMed Central  Google Scholar 

Querques G, et al. Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment. Sci Rep. 2019;9(1):63.

Article  PubMed  PubMed Central  Google Scholar